Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ZBH | Phantom Stock Units | Award | $0 | +500 | +1.64% | $0.00 | 31K | May 12, 2023 | Common Stock | 500 | $136.73 | Direct | F1, F2, F3, F4 |
transaction | ZBH | Restricted Stock Units | Award | $0 | +951 | +4.44% | $0.00 | 22.4K | May 12, 2023 | Common Stock | 951 | Direct | F2, F5, F6 |
Id | Content |
---|---|
F1 | The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. |
F2 | The Conversion or Exercise Price of Derivative Security is 1-for-1. |
F3 | Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. |
F4 | Includes 52.364 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
F5 | The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. |
F6 | Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. |